Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- [Phase 2, Phase 3]
This clinical trial update reports the completion of a Phase 2/3 study evaluating the efficacy and safety of DE-117 ophthalmic solution in a…
-
FDA approval · 2017-11-02FDA Approved: VYZULTA — Original Application (Bausch & Lomb Incorporated)
FDA approved VYZULTA (latanoprostene bunod), from Bausch & Lomb, as a new treatment for open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension [Phase 1]
A Phase 1 pharmacokinetics study of tafluprost ophthalmic solution (0.0015%) in pediatric patients with glaucoma or ocular hypertension has …
-
FDA label_change · 2017-09-22FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for TRAVATAN Z (travoprost) from Novartis Pharmaceuticals Corporation, resulting in updated labe…
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of a fixed-dose combination of brinzolamide and brimonidine given twice daily versus separ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma [Phase 1, Phase 2]
Clinical trial update on MGV354 in ocular hypertension and open-angle glaucoma across Phase 1 and Phase 2. The results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness [Phase 4]
Phase 4 study evaluating tear film thickness after switching from preserved prostaglandin formulations to preservative-free tafluprost; the …
-
FDA approval · 2017-07-29FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Lumigan (bimatoprost) from Allergan, Inc. The action updates the product through labeling change…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma [Phase 4]
This Phase 4 clinical trial update compares Xalatan (latanoprost) with Apo-latanoprost and Co-latanoprost for glaucoma and ocular hypertensi…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension [Phase 4]
Phase 4 trial evaluating the efficacy of brand-name latanoprost versus a generic latanoprost in primary open-angle glaucoma and ocular hyper…
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily [Phase 2]
An exploratory Phase 2 trial comparing D565H twice daily versus D565 once daily for open-angle glaucoma and ocular hypertension. The documen…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension
A long-term trial update on the use of Xalacom in patients with glaucoma or ocular hypertension, with completed status and results posted in…
-
FDA approval · 2017-07-07FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's travoprost ophthalmic solution 0.004% through an original application for lowering intraocular pressure in open-angle g…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery [NA]
This clinical trial update reports on the efficacy and safety outcomes comparing the ExPRESS implant with deep sclerectomy in combined glauc…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy [NA]
Clinical trial update reporting results for selective laser trabeculoplasty after failed phacoemulsification with excimer laser trabeculecto…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Divided Dose of TRAVATAN® [Phase 2]
Phase 2 trial evaluating divided dosing of TRAVATAN for open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation
The trial evaluated whether training could help glaucoma patients who have difficulty instilling eye drops. The study was terminated.
-
FDA approval · 2017-04-06FDA Approved: APRACLONIDINE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for apraclonidine filed by Sandoz Inc to modify/expand the drug's labeling or use.
-
FDA approval · 2017-04-06FDA Approved: TIMOPTIC IN OCUDOSE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC IN OCUDOSE (timolol maleate) submitted by Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension [Phase 1, Phase 2]
The update provides safety and efficacy data for Deep Wave Trabeculoplasty (DWT) in primary open-angle glaucoma and ocular hypertension. The…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153) [Phase 3]
A Phase 3 study evaluating Cosopt as first-line therapy for glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS research · 2017-03-31Clinical Trial Update: Effect of Steep Trendelenburg in Laparoscopic Surgery on IOP & RNFL Thickness [NA]
A clinical trial update studying the effect of steep Trendelenburg positioning during laparoscopic surgery on intraocular pressure and retin…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial) [Phase 4]
Completed Phase 4 trial comparing Xalatan alone versus Xalatan in combination with Cosopt to assess diurnal intraocular pressure in eye dise…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings [NA]
A completed clinical trial evaluating whether horizontal versus vertical positioning of the iCare Rebound Tonometer alters intraocular press…
-
FDA approval · 2017-02-01FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride), a beta-blocker ophthalmic solution. The product is manufac…